michael l - pophealth.wisc.edu

Approved August 3, 2010 All sections may not apply to all faculty members. If a section does not apply, either omit or note “Not Applicable.” Applies to: Candidates for Appointment & Promotion to Associate & Full Professor on CHS & C-T tracks; Promotion

to Full Professor on Tenure Track

Brad C. Astor, PhD, MPH

1/29/21

Personal Data

Office: University of Wisconsin School of Medicine and Public Health (UWSMPH) 5149 Medical Foundation Centennial Building 1685 Highland Avenue Madison, WI 53705 Phone: (608) 262-0361 E-mail: [email protected]

Education B.S.E. 1983-1987 Biomedical Engineering; University of Iowa M.S. 1988-1991 Electrical Engineering; The Johns Hopkins University

M.P.H. 1992-1996 The Johns Hopkins University School of Hygiene and Public Health

Ph.D. 1996-2000 Epidemiology; The Johns Hopkins University School of Hygiene and Public Health Thesis: Vascular Access for Hemodialysis 2000-2002 Post-doctoral Fellowship, Department of Epidemiology, The Johns

Hopkins Bloomberg School of Public Health Present Appointment/Position

2019-present Professor (with tenure), Departments of Medicine and Population Health

Sciences, University of Wisconsin School of Medicine and Public Health Past Appointments/Positions 2011-2019 Associate Professor, Departments of Medicine and Population Health

Sciences, University of Wisconsin School of Medicine and Public Health 2008-2011 Associate Professor, Departments of Epidemiology and Medicine, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 2005-2008 Assistant Professor, Division of General Internal Medicine, Department of

Medicine, Johns Hopkins School of Medicine (joint appointment), Baltimore, MD

2002-2008 Assistant Professor, Department of Epidemiology, The Johns Hopkins

Bloomberg School of Public Health, Baltimore, MD

1/29/21



1998-2000 Epidemiologist; Office of Surveillance and Biometrics, United States Food

and Drug Administration, Rockville, MD 1987-1998 Scientific reviewer; Interventional Cardiology Devices Branch, United

States Food and Drug Administration, Rockville, MD Honors and Awards

2019 Rankin Research Award, Department of Medicine 2017 Research Excellence Award, Division of Nephrology 2012 Department of Medicine Research Day Award; Serum ß2-microglobulin at

discharge predicts mortality and graft loss following kidney transplantation 2012 Research Excellence Award, Division of Nephrology 2004 Faculty Innovation Fund, Department of Epidemiology Moderate kidney

dysfunction, anemia and coronary calcification in the Multi Ethnic Study of Atherosclerosis (MESA)

2002 Harry and Jeanette Weinberg Endowment Cardiovascular Research Award; American Heart Association, Mid-Atlantic Affiliate; Associations of mild kidney dysfunction and anemia with left ventricular hypertrophy and mortality

2000 Charlotte Silverman Fellowship; departmental recognition for student research 1999 Mary B. Meyer Award; highest departmental academic award 1999 Delta Omega Public Health Honorary Society Alpha Chapter Scholarship; A

prospective study of plasma fibrinogen as a risk factor for vascular access complications

1999 Jean Coombs Award for Student Research in Epidemiology; The epidemiology of bioprosthetic and mechanical heart valve implantations in the United States

Grant Support

Current

APOL1 Long-term Kidney Transplantation Outcomes Network - Upper Midwest NIH/NIDDK (U01) Year 4 amount: $554,006 2017-2022 PI: Astor (30% effort)

Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant NIH/NIDDK (R01) Year 1 amount: $510,660

2019-2024 PI: Astor (Multiple) (10% effort)

Major Past Awards

Vitamin D, magnesium, and immune-mediated outcomes in kidney transplant recipients UW Research Committee (2018 Fall Research Competition) Year 1 amount: 41,137 2019-2020 PI: Astor (0% effort)



Association of Mineral Metabolites with Vascular Access Outcomes

American Society for Diagnostic and Interventional Nephrology $25,000 total costs 2016-2018 PI: Astor (0% effort) Endogenous Cardiac Glycosides in the Development of Cardiovascular Disease in African Americans with Hypertensive Nephrosclerosis NIH/NIDDK (R21) Year 5 amount: $139,496 2009-2013 PI: Astor (15% effort) Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease NIH/NIDDK (R01) Year 5 amount: $669,552 2007-2013 PI: Astor (20% effort)

Institute for Clinical and Translational Research (ICTR) NIH/Center for Research Resources Year 4 amount: $15,683,386 2007-2011 PI: Ford Role: Co-Investigator (12.5% effort)

Atherosclerosis Risk in Communities (ARIC) Study NIH/NHLBI Year 10 amount: $1,981,954 2000-2011 PI: Coresh Role: Co-Investigator (5% effort) Complications & Prognosis of CKD in the US Population National Kidney Foundation Year 2 amount: $150,000 2009-2011 PI: Coresh Role: Co-Investigator (25% effort) Proteomic Approach to CKD Biomarker Discovery and Validation NIH/NIDDK Year 2 amount: $814,233 2009-2011 PI: Coresh Role: Co-Investigator (5% effort) Prospective Study of Atherosclerosis, Clinical Cardiovascular Disease, and Long Term Exposure to Ambient Particulate Matter and Other Air Pollutants in a Multi Ethnic Cohort



(MESA Air) Environmental Protection Agency Year 5 amount: $163,424 2004-2010 PI: Astor (15% effort)

African American Study of Kidney Disease and Hypertension (AASK) Cohort Study NIH/NIDDK (U01)

Year 6 amount: $416,559 2000-2007

PI: Astor (2006-2007) (10% effort) Associations of Mild Kidney Dysfunction and Anemia with Left Ventricular Hypertrophy and Mortality American Heart Association Year 2 amount: $65,491 2002-2005 PI: Astor (10%)

Publications

Refereed Articles 1. Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ. Relation between gender and

vascular access complications in hemodialysis patients. Am J Kidney Dis 2000;36:1126-1134.

2. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg 2000;70:1939-1945.

3. Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler J, Fink NE, Coresh J. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis 2001;38:494-501.

4. Astor BC, Eustace JA, Klag MJ, Powe NR, Longenecker JC, Fink NE, Marcovina SM, Coresh J. Race-specific association of lipoprotein(a) with vascular access interventions in incident hemodialysis patients: the CHOICE Study. Kidney Int 2002;61:1115-1123.

5. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-929

6. Astor BC, Muntner M, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002;162:1401-1408.

7. Kovesdy CP, Astor BC, Longenecker JC, Coresh J. Association of kidney function with serum lipoprotein(a) level: the Third National Health and Nutrition Examination Survey (1991-1994). Am J Kidney Dis 2002;40:899-908.

8. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002;41:1-12.



9. Eustace JA, Astor BC, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004;65(3):1031-40.

10. Jaar BG, Astor BC, Berns JS, Powe NR. Predictors of lower extremity amputation and survival of hemodialysis patients following revascularization for peripheral vascular disease. Kidney Int. 2004;65:613-20.

11. Coresh J, Astor BC, Sarnak MJ. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004;13:73-81.

12. Astor BC, Arnett DK, Brown A, Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2004;43:836-845.

13. Christopher-Stine L, Petri M, Astor BC, Fine D. Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. J Rheumatol 2004;31:1557-1559.

14. Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the Third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004;89:6077-6086.

15. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence and trends among US adults, 1999-2000. J Am Soc Nephrol 2005;16:180-188.

16. Wasserman BA, Casal SG, Astor BC, Aletras BC, Arai AE. Wash-in kinetics for Gadolinium enhanced MRI of carotid atheroma, J Magn Reson Imaging 2005;21:91-95.

17. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 2005;16:529-538.

18. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. Type of vascular access and survival among incident hemodialysis patients: the CHOICE Study. J Am Soc Nephrol 2005;16:1449-1455.

19. Eustace JA, Gregory PC, Krishnan M, Ni W, Kuhn DM, Astor BC, Scheel PJ Jr. Influence of intravenous drug abuse on vascular access placement and survival in HIV-seropositive patients. Nephron Clin Pract 2005;100:c38-c45.

20. Goldberg MC, Mostofsky SH, Cutting LE, Mahone LE, Astor BC, Denckla MB, Landa RJ. Subtle executive impairment in children with autism and children with ADHD. J Autism Develop Disorders 2005;35:279-293.

21. Gorman G, Furth S, Hwang W, Parekh R, Astor BC, Fivush B, Frankenfield D, Neu A. Clinical outcomes and dialysis adequacy in adolescent hemodialysis patients. Am J Kidney Dis 2006;47:285-293.

22. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006;151:492-500.



23. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, Schwartz BS. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol 2006;163:700-708.

24. Hallan S, Astor BC, Lydersen S. Estimating glomerular filtration rate in the general population: the second Health Survey of Nord-Trondelag (HUNT II). Nephrol Dial Transplant 2006;21:1525-1533.

25. Diez Roux AV, Auchincloss AH, Astor BC, Barr RG, Cushman M, Dvonch T, Jacobs DR Jr, Kaufman J, Lin X, Samson P. Recent exposure to particulate matter and C-reactive protein concentration in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006;164:437-448.

26. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;17:2275-2284.

27. Plantinga LC, Jaar BG, Astor BC, Fink NE, Eustace JA, Klag MJ, Powe NR. Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patients. Nephron Clin Pract 2006;104:c151-159.

28. Coresh J, Astor BC. Decreased kidney function in the elderly: clinical and preclinical, neither benign. Ann Intern Med 2006;145:299-301.

29. Babiarz LS, Astor BC, Mohamed MA, Wasserman BA. Comparison of gadolinium-enhanced cardiovascular magnetic resonance angiography with high-resolution black blood cardiovascular magnetic resonance for assessing carotid artery stenosis. J Cardiovasc Magn Reson 2007;9:63-70.

30. Hyre AD, Fox CS, Astor BC, Cohen AJ, Muntner P. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment. Am J Kidney Dis 2007;49:37-45.

31. Yeung EH, Pankow JS, Astor BC, Powe NR, Saudek CD, Kao WH. Increased risk of type 2 diabetes from a family history of coronary heart disease and type 2 diabetes. Diabetes Care 2007;30:154-156.

32. Silber HA, Lima JA, Bluemke DA, Astor BC, Gupta SN, Foo TK, Ouyang P. Arterial reactivity in lower extremities is progressively reduced as cardiovascular risk factors increase comparison with upper extremities using magnetic resonance imaging. J Am Coll Cardiol. 2007;49:939-45.

33. Siedner MJ, Christopher-Stine L, Astor BC, Gelber AC, Fine DM. Screening for proteinuria in patients with Lupus: A survey of practice preferences among American rheumatologists. J Rheumatol 2007;34:973-7.

34. Jaar BG, Plantinga LC, Astor BC, Fink NE, Longenecker C, Tracy RP, Marcovina SM, Powe NR, Coresh J. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients. Adv Chronic Kidney Dis 2007;14:304-13.

35. de Boer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atheroslcerosis (MESA). Atherosclerosis 2007;197:407-14.



36. O’Neill MS, Diez-Roux AV, Auchincloss AH, Franklin TG, Jacobs DR, Astor BC, Dvonch JT, Kaufman J. Airborne particulate matter exposure and urinary albumin excretion: The Multi-Ethnic Study of Atherosclerosis. Occup Environ Med 2007.

37. Hallan S, Astor BC, Romundstad S, Aasarød K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007;167:2490-6.

38. Seidner MJ, Gelber AC, Rovin BH, McKinley AM, Christopher-Stine L, Astor BC, Petri M, Fine DM. Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis. J Rheumatol 2008;35:84-90.

39. de Boer IH, Astor BC, Kramer H, Palmas W, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2008;3:125-32.

40. Astor BC, Hallan SI, Miller ER III, Yeung E, Coresh J. Glomerular filtration rate, albuminuria and risk of cardiovascular and all cause mortality in the US population. Am J Epidemiol 2008;167:1226-34.

42. Diez Roux AV, Auchincloss AH, Franklin TG, Raghunathan T, Barr RG, Kaufman J, Astor BC, Keeler J. Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2008;167:667-75.

43. Astor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson B, Lewis J, Lash JP, Van Lente F, Gassman J, Wang X, Bakris G, Appel LJ, Contreras G. N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a predictor of cardiovascular disease and mortality in African Americans with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK). Circulation 2008;117:1685-92.

44. Kottgen A, Kao WH, Hwang SJ, Boerwinkle E, Yang Q, Levy D, Benjamin EJ, Larson MG, Astor BC, Coresh J, Fox CS. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 2008;9:49.

45. Melamed ML, Michos ED, Post W, Astor BC. 25-hydroxyvitamin D Levels and the risk of mortality in the general population. Arch Intern Med 2008:168:1629-37.

46. Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 2008;52:1051-60.

47. Kramer H, Palmas W, Kestenbaum B, Cushman M, Allison M, Astor BC, Shlipak M. Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ehtnic Study of Atherosclerosis. Clin J Am Soc Nephrol 2008;3:1391-7.

48. Yi S, Contreras G, Miller ER 3rd, Appel LJ, Astor BC. Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African-American Study of Kidney Disease and Hypertension. Am J Nephrol 2008;29:292-298.



49. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WH, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008;372:1953-61.

50. Bash LD, Selvin E, Steffes MW, Coresh J, Astor BC. Poor glycemic control in diabetes and the the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: The Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med 2008;168:1-8.

51. Moran A, Katz R, Jenny NS, Astor BC, Bluemke DA, Lima JAC, Siscovick D, Bertoni AG, Shlipak MG. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kid Dis 2008;52:839-848.

52. Tamariz LJ, Young H, Pankow JS, Yeh HC, Schmidt MI, Astor BC, Brancati FJ. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2008;168:1153-1160.

53. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53:596-605.

54. Hsu CC, Brancati FL, Astor BC, Kao WH, Steffes MW, Folsom AR, Coresh J. Blood pressure, atherosclerosis, and albuminuria in 10,113 participants of the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens. 2009;27:397-409.

55. Yi S, Selvin E, Rohrmann S, Basaria S, Menke A, Rifai N, Guallar E, Platz EA, Astor BC. Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol. 2009;71:246-52.

56. Köttgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Ida Chen YD, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Paré G, Ridker PM, Kao WH, Witteman JC, Coresh J, Shlipak MG, Fox CS. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41:712-717.

57. Bash LD, Coresh J, Kottgen A, Parekh R, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2009;170:414-424.

58. McNeely MJ, McClelland RL, Bild DE, Jacobs DR Jr, Tracy RP, Cushman M, Goff DC Jr, Astor BC, Shea S, Siscovick DS. The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care. 2009;32:1727-1733.

59. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20:2214-2222.

60. Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M; for the Atherosclerosis Risk in Communities (ARIC) Study. Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010;25:3296-301.



61. Chu AY, Parekh RS, Astor BC, Coresh J, Berthier-Schaad Y, Smith MW, Shuldiner AR, Kao WH. Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Med Genet. 2009;10:108.

62. Melamed ML, Astor BC, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009;20:2631-2639.

63. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and morality. J Am Soc Nephrol. 2009;20:2617-2624.

64. Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010;55:31-41.

65. Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Coresh J, Chambless L, Ballantyne CM. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) Study. J Am Coll Cardiol. 2009;54:2388-2395.

66. Wasserman BA, Astor BC, Sharrett AR, Swingen C, Catellier D. MRI measurements of carotid plaque in the Atherosclerosis Risk in Communities (ARIC) Study: methods, reliability and descriptive statistics. J Magn Reson Imaging. 2010;31:406-415.

67. Estrella MM, Astor BC, Köttgen A, Selvin E, Coresh J, Parekh RS. Prevalence of kidney disease in anaemia differs by GFR-estimating method: The Third National Health and Nutrition Examination Survey (1988-94). Nephrol Dial Transplant. 2010;25:2542-2548.

68. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010;55:648-659.

69. Folsom AR, Lutsey PL, Astor BC, Cushman M. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost. 2009;102:615-9.

70. Levey AS, Astor BC, Stevens LA, Coresh J. Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int. 2010;78:19-22.

71. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.

72. Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2010;25:2542-8.



73. Bi M, Kao WH, Boerwinkle E, Hoogeveen RC, Rasmussen-Torvik LJ, Astor BC, North KE, Coresh J, Köttgen A. Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study. PLos One 2010;5:e11690.

74. Brotman DJ, Bash LD, Qayyum R, Crews D, Whitsel EA, Astor BC, Coresh J. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010;21:1560-70.

75. Astor BC, Sharrett AR, Coresh J, Chambless LE, Wasserman BA. Remodeling of the carotid arteries detected with MR imaging: Atherosclerosis Risk in Communities Carotid MRI Study. Radiology 2010;256:879-86.

76. Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J. Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 2010;21:1757-64.

77. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010;363:918-929.

78. Crawford SO, Hoogeveen RC, Brancati FL, Astor BC, Ballantyne CM, Schmidt MI, Young JH. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol. 2010;39:1647-55.

79. Toto RD, Greene T, Hebert LA, Hiremath L, Lea JP, Lewis JB, Pogue V, Sika M, Wang X; AASK Collaborative Research Group. Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis 2010;56:896-906.

80. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010;363:918-29.

81. Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT Jr, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ; African-American Study of Kidney Disease, and Hypertension Study Group. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol 2010;21:2131-42.

82. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2010;60:298-305.

83. Muntner P, Lee F, Astor BC. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: The Atherosclerosis Risk in Communities Study. Am J Med Sci 2010.



84. Franceschini N, Rose KM, Astor BC, Couper D, Vupputuri S. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension 2010;56:1054-9.

85. Levey AS, de Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2010;80:17-28.

86. Qiao Y, Etesami M, Malhotra S, Astor BC, Virmani R, Kolodgie FD, Trout HH 3rd, Wasserman BA. Identification of intraplaque hemorrhage on MR angiography images: a comparison of contrast-enhanced mask and time-of-flight techniques. Am J Neuroradiol. 2011;32:454-9.

87. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, Jong PE, Coresh J; The Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93-104.

88. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J; The Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331-40.

89. O’Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS. Lower Urinary Connective Tissue Growth Factor Levels and Incident CKD Stage 3 in the General Population. Am J Kidney Dis. 2011.

90. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, Baumert J, Strachan DP, Fuchsberger C, Vitart V, Wilson JF, Paré G, Naitza S, Rudock ME, Surakka I, de Geus EJ, Alizadeh BZ, Guralnik J, Shuldiner A, Tanaka T, Zee RY, Schnabel RB, Nambi V, Kavousi M, Ripatti S, Nauck M, Smith NL, Smith AV, Sundvall J, Scheet P, Liu Y, Ruokonen A, Rose LM, Larson MG, Hoogeveen RC, Freimer NB, Teumer A, Tracy RP, Launer LJ, Buring JE, Yamamoto JF, Folsom AR, Sijbrands EJ, Pankow J, Elliott P, Keaney JF, Sun W, Sarin AP, Fontes JD, Badola S, Astor BC, Hofman A, Pouta A, Werdan K, Greiser KH, Kuss O, Meyer zu Schwabedissen HE, Thiery J, Jamshidi Y, Nolte IM, Soranzo N, Spector TD, Völzke H, Parker AN, Aspelund T, Bates D, Young L, Tsui K, Siscovick DS, Guo X, Rotter JI, Uda M, Schlessinger D, Rudan I, Hicks AA, Penninx BW, Thorand B, Gieger C, Coresh J, Willemsen G, Harris TB, Uitterlinden AG, Järvelin MR, Rice K, Radke D, Salomaa V, Willems van Dijk K, Boerwinkle E, Vasan RS, Ferrucci L, Gibson QD, Bandinelli S, Snieder H, Boomsma DI, Xiao X, Campbell H, Hayward C, Pramstaller PP, van Duijn CM, Peltonen L, Psaty BM, Gudnason V, Ridker PM, Homuth G, Koenig W, Ballantyne CM, Witteman JC, Benjamin EJ, Perola M, Chasman DI. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123:731-8.

91. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT; the Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011;79:1341-52.



92. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011;123:1367-76.

93. Davis EM, Appel LJ, Wang X, Greene T, Astor BC, Rahman M, Toto R, Lipkowitz MS, Pogue VA, Wright JT Jr; for the African American Study of Kidney Disease and Hypertension Research Collaborative Group. Limitations of Analyses Based on Achieved Blood Pressure: Lessons From the African American Study of Kidney Disease and Hypertension Trial. Hypertension. 2011;57:1061-1068.

94. Bekwelem W, Lutsey PL, Loehr LR, Agarwal SK, Astor BC, Guild C, Ballantyne CM, Folsom AR. White Blood Cell Count, C-Reactive Protein, and Incident Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2011;21:739-48.

95. Sarnak MJ, Astor BC. Implications of Proteinuria: CKD Progression and Cardiovascular Outcomes. Adv Chronic Kidney Dis. 2011;18:258-66.

96. Scialla JJ, Appel LJ, Astor BC, Miller ER 3rd, Beddhu S, Woodward M, Parekh RS, Anderson CA. Estimated net endogenous Acid production and serum bicarbonate in african americans with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1526-32.

97. Astor BC, Kottgen A, Hwang SJ, Bhavsar N, Fox CS, Coresh J. Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) Study. Am J Nephrol. 2011;34:291-7.

98. Astor BC, Bhavsar NA. Is there something better than the best marker of kidney function? J Am Soc Nephrol. 2011;22:1779-81.

99. Liu CT, Garnaas MK, Tin A, Kottgen A, Franceschini N, Peralta CA, de Boer IH, Lu X, Atkinson E, Ding J, Nalls M, Shriner D, Coresh J, Kutlar A, Bibbins-Domingo K, Siscovick D, Akylbekova E, Wyatt S, Astor BC, Mychaleckjy J, Li M, Reilly MP, Townsend RR, Adeyemo A, Zonderman AB, de Andrade M, Turner ST, Mosley TH, Harris TB; CKDGen Consortium, Rotimi CN, Liu Y, Kardia SL, Evans MK, Shlipak MG, Kramer H, Flessner MF, Dreisbach AW, Goessling W, Cupples LA, Kao WL, Fox CS. Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet. 2011;7:e1002264.

100. Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis. 2011;58:886-92.

101. Qiao Y, Etesami M, Astor BC, Zeiler SR, Trout HH 3rd, Wasserman BA. Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. Am J Neuroradiol 2011;33:755-60.

102. Hermida J, Lopez FL, Montes R, Matsushita K, Astor BC, Alonso A. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2012;109:95-9.

103. Shafi T, Matsushita K, Selvin E, Sang Y, Astor BC, Inker LA, Coresh J. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III) examination survey (NHANES III). BMC Nephrol. 2012;13:42.



104. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59:504-12.

105. Goek ON, Köttgen A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC. Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples. Nephrol Dial Transplant. 2012;27:2839-47.

106. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59:653-62.

107. O'Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, D'Agostino RB Sr, Astor BC, Fox CS. A risk score for chronic kidney disease in the general population. Am J Med. 2012;125:270-7.

108. Hu B, Gadegbeku C, Lipkowitz MS, Rostand S, Lewis J, Wright JT, Appel LJ, Greene T, Gassman J, Astor BC; Kidney function can improve in patients with hypertensive CKD. African-American Study of Kidney Disease and Hypertension Group. J Am Soc Nephrol. 2012;23:706-13.

109. Scialla JJ, Appel LJ, Astor BC, Miller ER 3rd, Beddhu S, Woodward M, Parekh RS, Anderson CA. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int. 2012;82:106-12.

110. Waheed S, Matsushita K, Sang Y, Hoogeveen R, Ballantyne C, Coresh J, Astor BC. Combined Association of Albuminuria and Cystatin C-Based Estimated GFR With Mortality, Coronary Heart Disease, and Heart Failure Outcomes: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2012;60:207-16.

111. Bhavsar NA, Köttgen A, Coresh J, Astor BC. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2012;60:233-40.

112. Agarwal SK, Chambless LE, Ballantyne CM, Astor BC, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera M, Rosamond WD, Russell SD, Shahar E, Heiss G. Prediction of Incident Heart Failure in General Practice: The ARIC Study. Circ Heart Fail. 2012;5:422-9.

113. Etesami M, Hoi Y, Steinman DA, Gujar SK, Nidecker AE, Astor BC, Portanova A, Qiao Y, Abdalla WM, Wasserman BA. Comparison of Carotid Plaque Ulcer Detection Using Contrast-Enhanced and Time-of-Flight MRA Techniques. Am J Neuroradiol. 2012;34:177-84.

114. Astor BC. Chronic kidney disease: Estimating GFR-the right equation for the right population. Nat Rev Nephrol. 2012;8:379-80.

115. Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; the AASK Investigators. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int. 2012;83:114-20.

116. Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M. CKD, Plasma Lipids, and Common Carotid Intima-



Media Thickness: Results from the Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol. 2012;7:1777-85.

117. Mahmoodi BK, Gansevoort RT, Næss IA, Lutsey PL, Brækkan SK, Veeger NJ, Brodin EE, Meijer K, Sang Y, Matsushita K, Hallan SI, Hammerstrøm J, Cannegieter SC, Astor BC, Coresh J, Folsom AR, Hansen JB, Cushman M. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective population cohorts. Circulation 2012;126:1964-71.

118. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC; for the Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012;380:1649-61.

119. Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, Dasilva JR, Astor BC, Yevzlin AS, Humes HD. The Effect of the Selective Cytopheretic Device on Acute Kidney Injury Outcomes in the Intensive Care Unit: A Multicenter Pilot Study. Semin Dial. 2013;26:616-23

120. Ndumele CE, Matsushita K, Astor BC, Virani SS, Mora S, Williams EK, Hoogeveen RC, Blumenthal RS, Sharrett AR, Ballantyne CM, Coresh J. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: The ARIC Study. Eur J Prev Cardiol. 2012.

121. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012;308:2349-60.

122. Wolfgram DF, Foster D, Astor BC, Chan MR. Development of Clostridium difficile colitis in peritoneal dialysis patients treated for peritonitis. Perit Dial Int. 2012;32:666-8.

123. Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; for the Chronic Kidney Disease Prognosis Consortium. Cohort Profile: The Chronic Kidney Disease Prognosis Consortium. Int J Epidemiol. 2013;42:1660-8.

124. Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol. 2013;24:125-35.

125. Bhavsar NA, Coresh J, Astor BC. In Reply to 'Neutrophil Gelatinase-Associated Lipocalin (NGAL), Neutrophils, and CKD: Which Comes First?'. Am J Kidney Dis. 2013;61:184.

126. Waheed S, Matsushita K, Astor BC, Hoogeveen RC, Ballantyne C, Coresh J. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol. 2013;8:434-42.

127. Mongraw-Chaffin ML, Matsushita K, Brancati FL, Astor BC, Coresh J, Crawford SO, Schmidt MI, Hoogeveen RC, Ballantyne CM, Young JH. Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI study. PLoS One. 2012;7:e51237.



128. Tin A, Astor BC, Boerwinkle E, Hoogeveen RC, Coresh J, Kao WH. Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans. Nephrol Dial Transplant. 2013;28:1497-504

129. Lamprea-Montealegre JA, McClelland RL, Astor BC, Matsushita K, Shlipak M, de Boer IH, Szklo M. Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:652-8.

130. Juraschek SP, Coresh J, Inker LA, Levey AS, Köttgen A, Foster MC, Astor BC, Eckfeldt JH, Selvin E. Comparison of Serum Concentrations of β-Trace Protein, β2-Microglobulin, Cystatin C, and Creatinine in the US Population. Clin J Am Soc Nephrol. 2013;8:584-592.

131. Selvin E, Halushka M, Rawlings A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC. sRAGE and risk of diabetes, cardiovascular disease and death. Diabetes. 2013;62:2116-21.

132. Bloomfield GS, Yi SS, Astor BC, Kramer H, Shea S, Shlipak MG, Post WS. Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. J Hum Hypertens. 2013;27:421-6,

133. Mahmoodi BK, Fox CS, Astor BC, Nelson RG, Matsushita K, Coresh J; Chronic Kidney Disease Prognosis Consortium. Association of chronic kidney disease with adverse outcomes - Authors' reply. Lancet. 2013;381:532-3.

134. Tin A, Astor BC, Boerwinkle E, Hoogeveen RC, Coresh J, Kao WH. Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin. Hum Genet. 2013;132:619-27.

135. Astor BC, Shaikh S, Chaudhry M. Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens. 2013;22:331-5.

136. Shantha GP, Wasserman B, Astor BC, Coresh J, Brancati F, Sharrett AR, Young JH. Association of blood lactate with carotid atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Atherosclerosis. 2013;228:249-55.

137. Tin A, Colantuoni E, Boerwinkle E, Kottgen A, Franceschini N, Astor BC, Coresh J, Kao WH. Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate. J Hum Genet. 2013;58:461-6.

138. Astor BC, Muth B, Kaufman DB, Pirsch JD, Hofmann RM, Djamali A. Serum ß2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Kidney Int. 2013;84:810-7.

139. Wolfgram DF, Gundu V, Astor BC, Jhagroo RA. Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones. Urolithiasis. 2013;41:315-22.

140. Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol. 2013;24:1484-91.

141. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis



Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369:932-43.

142. Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, Coresh J. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013;178:1076-84.

143. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013;59:1802-10.

144. Agarwal G, Foster D, Schlageter K, Jones L, Jorgensen L, Wilkinson S, Astor BC, Chan MR. Increase in peritonitis rates with the reuse of drain tubing of the Fresenius Liberty cycler. Perit Dial Int. 2013;33:583-5.

145. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369:2183-96.

146. Chan MR, Shobande O, Vats H, Wakeen M, Meyer X, Bellingham J, Astor BC, Yevzlin AS. The effect of buttonhole cannulation vs. rope-ladder technique on hemodialysis access patency. Semin Dial. 2014;27:210-6.

147. O'Seaghdha CM, Tin A, Yang Q, Katz R, Liu Y, Harris T, Astor BC, Coresh J, Fox CS, Kao WH, Shlipak MG. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. Am J Kidney Dis. 2014;63:16-22.

148. Li L, Chang A, Rostand SG, Hebert L, Appel LJ, Astor BC, Lipkowitz MS, Wright JT, Kendrick C, Wang X, Greene TH. A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol. 2014;25:606-13.

149. Bower JK, Pankow JS, Lazo M, Christenson E, Hoogeveen RC, Ballantyne CM, Halushka MK, Astor BC, Selvin E. Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE). Clin Biochem. 2014;47:132-4.

150. Gepner AD, Korcarz CE, Colangelo LA, Hom EK, Tattersall MC, Astor BC, Kaufman JD, Liu K, Stein JH. Longitudinal effects of a decade of aging on carotid artery stiffness: the multiethnic study of atherosclerosis. Stroke. 2014;45:48-53.

151. Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang H, de Zeeuw D, Astor BC, Gansevoort RT, Levey AS, Levin A. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int. 2014;86:819-27.

152. Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis. 2014;234:42-6.



153. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713-35.

154. Richards KR, Hager D, Muth B, Astor BC, Kaufman D, Djamali A. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. Transplantation. 2014;97:986-91.

155. Mahmoodi BK, Yatsuya H, Matsushita K, Sang Y, Gottesman RF, Astor BC, Woodward M, Longstreth WT Jr, Psaty BM, Shlipak MG, Folsom AR, Gansevoort RT, Coresh J. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts. Stroke. 2014;45:1925-31.

156. Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol. 2014;34:1770-7.

157. Chan MR, Oza-Gajera B, Chapla K, Djamali AX, Muth BL, Turk J, Wakeen M, Yevzlin AS, Astor BC. Initial vascular access type in patients with a failed renal transplant. Clin J Am Soc Nephrol. 2014;9:1225-31.

158. Elramah M, Boujelbane L, Yevzlin AS, Wakeen M, Astor BC, Chan MR. Dialysis access venous stenosis: Treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int. 2014;19:108-14.

159. Sninsky BC, Jhagroo RA, Astor BC, Nakada SY. Do Multiple Ureteroscopies Alter Long-Term Renal Function? A Study Using Estimated Glomerular Filtration Rate. J Endourol. 2014;28:1295-8.

160. Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh J, Folsom AR. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2014; 100:756-64.

161. Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A.. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014;16:1426-33.

162. Rebholz CM, Astor BC, Grams ME, Halushka MK, Lazo M, Hoogeveen RC, Ballantyne CM, Coresh J, Selvin E. Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant. 2014;30:77-83.

163. Huang M, Matsushita K, Sang Y, Ballew SH, Astor BC, Coresh J. Association of Kidney Function and Albuminuria With Prevalent and Incident Hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2014;65:58-66.



164. Valliant AM, Chaudhry MK, Yevzlin AS, Astor BC, Chan MR. Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia. J Vasc Access. 2014;16:52-6.

165. Tattersall MC, Gassett A, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Astor BC, Sheppard L, Kronmal RA, Stein JH. Predictors of Carotid Thickness and Plaque Progression During a Decade: The Multi-Ethnic Study of Atherosclerosis.Stroke. 2014;45:3257-62.

166. Chan MR, Ghandour F, Murali NS, Washburn M, Astor BC. Pilot Study of the Effect of Lanthanum Carbonate (Fosrenol®) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study.J Nephrol Ther. 2014;4.

167. Chapla K, Oza-Gajera BP, Yevzlin AS, Shin JI, Astor BC, Chan MR. Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis. J Vasc Access. 2014;16:107-12.

168. Banerjee T, Kim SJ, Astor BC, Shafi T, Coresh J, Powe NR. Vascular Access Type, Inflammatory Markers, and Mortality in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014;64:954-61.

169. Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Selvin E, Coresh J, Kao WH. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int. 2014;87:820-7.

170. Fu N, Joachim E, Yevzlin AS, Shin JI, Astor BC, Chan MR. A Meta-analysis of Stent Placement vs. Angioplasty for Dialysis Vascular Access Stenosis. Semin Dial. 2014;28:311-7.

171. Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, McCullough PA, Vassalotti JA. Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One. 2014;26.

172. Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ. Estimating Time to ESRD Using Kidney Failure Risk Equations: Results From the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis. 2014;65:394-402.

173. Löffler AI, Cappola TP, Fang J, Hetzel SJ, Kadlec A, Astor BC, Sweitzer NK. Effect of renal function on prognosis in chronic heart failure. Am J Cardiol. 2015;115:62-8.

174. Al Rifai M, Schneider AL, Alonso A, Maruthur N, Parrinello CM, Astor BC, Hoogeveen RC, Soliman EZ, Chen LY, Ballantyne CM, Halushka MK, Selvin E. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Diabetes Complications. 2015;20:180-5.

175. Yevzlin AS, Astor BC. Alternative strategies needed to improve vascular access outcomes. Clin J Am Soc Nephrol. 2015;10:172-3.

176. Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ. Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK). Nephrol Dial Transplant. 2015. PMID;30:1329-35.



177. Rosenberg JE, Yevzlin AS, Chan MR, Valliant AM, Astor BC. Prediction of Arteriovenous Fistula Dysfunction: Can it be Taught? Semin Dial. 2015;28:544-7.

178. Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Fornage M, Parekh RS, Coresh J, Kao WH. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol. 2015;10:784-90.

179. Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group. A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. PLoS One. 2015;10.

180. Boujelbane L, Fu N, Chapla K, Melnick D, Redfield RR, Waheed S, Yevzlin AS, Shin JI, Astor BC, Chan MR. Percutaneous versus surgical insertion of PD catheters in dialysis patients: a meta-analysis. J Vasc Access. 2015;16:498-505.

183. Alexander N, Matsushita K, Sang Y, Ballew S, Mahmoodi BK, Astor BC, Coresh J. Kidney Measures with Diabetes and Hypertension on Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. Am J Nephrol. 2015;41:409-17.

184. Chang A, Greene TH, Wang X, Kendrick C, Kramer H, Wright J, Astor BC, Shafi T, Toto R, Lewis J, Appel LJ, Grams M. The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant. 2015;30:1870-7.

185. Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, Coresh J, Selvin E, Kao WH. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study. PLoS One. 2015;10:e0128452.

186. Redfield RR, McCune KR, Rao A, Sadowski E, Hanson M, Kolterman AJ, Robbins J, Guite K, Mohamed M, Parajuli S, Mandelbrot DA, Astor BC, Djamali A. Nature, Timing and Severity of Complications from Ultrasound Guided Percutaneous Renal Transplant Biopsy. Transpl Int. 2015;29:167.

187. Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015;32:25-34.

188. Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF. Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2015;71:772-9.

189. Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clin J Am Soc Nephrol. 2015;10:2128-35.

190. Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M. Predictors and outcomes of delayed graft function after living-donor kidney transplantation. Transpl Int. 2016;29:81-7.

191. Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E. Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study. Am Heart J. 2015;170:961-7.



192. Muth BL, Astor BC, Turk J, Mohamed M, Parajuli S, Kaufman DB, Mandelbrot DA, Djamali A. Outpatient Management of Delayed Graft Function is Associated with Reduced Length of Stay without an Increase in Adverse Events. Am J Transplant. 2015;16:1604-11.

193. Gori M, Gupta DK, Claggett B, Selvin E, Folsom AR, Matsushita K, Bello NA, Cheng S, Shah A, Skali H, Vardeny O, Ni H, Ballantyne CM, Astor BC, Klein BE, Aguilar D, Solomon SD. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2016;39:677-85.

194. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016;315:164-74.

195. Parajuli S, Muth BL, Turk JA, Astor BC, Mohammed M, Mandelbrot DA, Djamali A. In Kidney Transplant Recipients With a Positive Virtual Crossmatch, High PRA was Associated With Lower Incidence of Viral Infections. Transplantation. 2016;100:655-61.

196. Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A. Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria. Hum Immunol. 2016;77:346-52.

197. Mohamed M, Parajuli S, Muth B, Astor BC, Panzer SE, Mandelbrot D, Zhong W, Djamali A. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss. Transpl Infect Dis. 2016;18:361-71.

198. Shin JI, Palta M, Djamali A, Kaufman DB, Astor BC. The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD). Transplantation. 2016;100:1541-9.

199. Rosenberg JE, Astor BC, Deluca HF, Yevzlin AS. The association of mineral metabolism with vascular access patency. J Vasc Access. 2016;17:392-96.

200. Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016;253:156-163.

201. Parajuli S, Odorico J, Astor BC, Djamali A, Sollinger H, Redfield R, Kaufman D, Mandelbrot DA. Incidence and Indications for Late Allograft Pancreatectomy while on Continued Immunosuppression. Transplantation. 2016;101:2228-2234.

202. Parajuli S, Redfield RR, Astor BC, Djamali A, Kaufman DB, Mandelbrot DA. Outcomes in the highest panel reactive antibody recipients of deceased donor kidneys under the new kidney allocation system. Clin Transplant. 2016;31.



203. Joachim E, Gardezi AI, Chan MR, Shin JI, Astor BC, Waheed S. Association of pre-transplant dialysis modality and post-transplant outcomes: a meta-analysis. Perit Dial Int. 2016;37:259-265.

204. Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF. Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2016;71:772-9.

205. Condon AJ, Astor BC, Holdener KE, Ellis TM, Djamali A. Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD). Clin Transpl. 2016;32:134-141.

206. Saxena N, Djamali A, Astor BC, Mohamed M, Mandelbrot D, Parajuli S. A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma. Clin Nephrol. 2017;88:40-44.

207. Parajuli S, Arpali E, Astor BC, Djamali A, Aziz F, Redfield RR, Sollinger HW, Kaufman D, Odorico J, Mandelbrot D. Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrates high rates of discordance for rejection as well as discordance in type of rejection. Transpl Int. 2017;31:32-37.

208. Astor BC, Melamed ML, Mandelbrot DA, Djamali A. Seasonality of Mortality and Graft Failure among Kidney Transplant Recipients in the US. Transpl Int. 2018;31:293-301.

209. Jorgenson MR, Descourouez JL, Singh T, Astor BC, Panzer SE. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease. Pharmacotherapy. 2018;38:51-57.

210. Singh T, Astor BC, Zhong W, Mandelbrot D, Djamali A, Panzer S. Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides. Transplant Direct. 2017;3.

211. Shin JI, Palta M, Djamali A, Astor BC. Higher Pretransplantation Hemoglobin A1c Is Associated With Greater Risk of Post-transplant Diabetes Mellitus. Kidney Int Rep. 2017;2:1076-1087.

212. Parajuli S, Mandelbrot DA, Muth B, Mohamed M, Garg N, Aziz F, Redfield RR, Zhong W, Astor BC, Djamali A. Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. Transplant Direct. 2017;3.

213. Williams C, Borges K, Banh T, Vasilevska-Ristovska J, Chanchlani R, Ng VL, Dipchand AI, Solomon M, Hebert D, Kim SJ, Astor BC, Parekh RS. Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients. Am J Transplant. 2018;18:1481-1488.

214. Parajuli S, Astor BC, Kaufman D, Muth B, Mohamed M, Garg N, Djamali A, Mandelbrot DA. Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection? Clin Transplant. 2018;32.

215. Hertz-Tang AL, Astor BC, Mandelbrot DA, Mohamed MA, Djamali A, Parajuli S. BK Viremia is Not Associated with Adverse Outcomes in the Absence of BK Nephropathy. Clin Transplant. 2018.

216. Parajuli S, Wick A, Pandeya S, Astor BC, Smith J, Djamali A, Mandelbrot DA. The Feared Five Fungal Infections in Kidney Transplant Recipients: A Single Center 20-year Experience. Clin Transplant. 2018.



217. Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC. Risk Factors for Prognosis in Patients With Severely Decreased GFR. Kidney Int Rep. 2018;3:625-637.

218. Plafkin C, Singh T, Astor BC, Parajuli S, Bhutani G, Safdar N, Panzer SE. Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes. Transpl Infect Dis. 2018

219. Quinn CS, Jorgenson MR, Descourouez JL, Muth BL, Astor BC, Mandelbrot DA. Management of Tumor Necrosis Factor α Inhibitor Therapy After Renal Transplantation: A Comparative Analysis and Associated Outcomes. Ann Pharmacother. 2018

220. Zhang Y, Guallar E, Malhotra S, Astor BC, Polak JF, Qiao Y, Gomes AS, Herrington DM, Sharrett AR, Bluemke DA, Wasserman BA. Carotid Artery Wall Thickness and Incident Cardiovascular Events: A Comparison between US and MRI in the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology. 2018;289:649-657

221. Parajuli S, Redfield RR, Garg N, Aziz F, Mohamed M, Astor BC, Zhong W, Djamali A, Mandelbrot DA. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation. Transplantation. 2018

222. Lyu B, Banerjee T, Scialla JJ, Shafi T, Yevzlin AS, Powe NR, Parekh RS, Astor BC. Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018;48:330-338

223. Garg N, Jorgenson M, Descourouez J, Saddler CM, Parajuli S, Astor BC, Djamali A, Mandelbrot D. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. BMC Nephrol. 2018;19:332

224. Parajuli S, Mandelbrot DA, Aziz F, Garg N, Muth B, Mohamed M, Armbrust MJ, Astor BC, Djamali A. Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years. Kidney Dis. 2018;4:255-261

225. Rolak S, Di Bartolomeo S, Jorgenson MR, Saddler CM, Singh T, Astor BC, Parajuli S. Outcomes of Norovirus Diarrheal Infections and Clostridioides difficile Infections in Kidney Transplant Recipients: A Single-Center Retrospective Study. Transpl Infect Dis. 2019

226. Djamali A, Singh T, Melamed ML, Stein JH, Aziz F, Parajuli S, Mohamed M, Garg N, Mandelbrot D, Wesson DE, Astor BC. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study. Am J Kidney Dis. 2019

227. Gardezi AI, Karim MS, Rosenberg JE, Scialla JJ, Banerjee T, Powe NR, Shafi T, Parekh RS, Yevzlin AS, Astor BC. Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodial Int. 2019

228. Parajuli S, Aziz F, Garg N, Panzer SE, Joachim E, Muth B, Mohamed M, Blazel J, Zhong W, Astor BC, Mandelbrot DA, Djamali A. Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression. World J Transplant. 2019



229. Li L, Yang W, Astor BC, Greene T. Competing Risk Modeling: Time to Put it in Our Standard Analytical Toolbox. J Am Soc Nephrol. 2019

230. Tiwari R, Lyu B, Alagusundaramoorthy S, Astor BC, Mandelbrot DA, Parajuli S. Association of diagnosed obstructive sleep apnea with kidney transplant outcomes. Clin Transplant. 2019

231. Singh T, Astor BC, Zhong W, Mandelbrot DA, Maursetter L, Panzer SE. The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation. Clin Transplant. 2019

232. Di Bartolomeo S, Rolak S, Joachim E, Xu YG, Astor BC, Parajuli S. Outcomes of malignant melanoma in kidney transplant recipients. Clin Nephrol. 2019

233. Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J. Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data. J Am Soc Nephrol. 2019

234. Singh T, Peery S, Astor BC, Parajuli S, Djamali A, Panzer SE. Cause of End-Stage Renal Disease Is Not a Risk Factor for Cytomegalovirus Infection After Kidney Transplant. Transplant Proc. 2019

235. Aziz F, Parajuli S, Uddin S, Harrold K, Djamali A, Astor B, Odorico J, Mandelbrot D How Should Pancreas Transplant Rejection Be Treated? Transplantation. 2019

236. Jorgenson MR, Descourouez JL, Lyu B, Astor BC, Garg N, Smith JA, Mandelbrot DA. The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients. Clin Transplant. 2019

237. Panzer SE, Joachim E, Parajuli S, Zhong W, Astor BC, Djamali A. Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy. Kidney Int Rep. 2019

238. Jorgenson MR, Descourouez JL, Astor BC, Smith JA, Aziz F, Redfield RR, Mandelbrot DA. Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year Perspective. Virology. 2019

239. Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM, Smith JA, Mandelbrot DA. Risk of opportunistic infection in kidney transplant rcipients with cytomegalovirus infection and associated outcomes. Transpl Infect Dis. 2019

240. Singh T, Astor BC, Waheed S. End-Stage Renal Disease Patients with Low Serum Albumin: Is Peritoneal Dialysis an Option? Perit Dial Int. 2019

241. Garg N, Kumar N, Singh T, Parajuli S, Astor BC, Mandelbrot D, Djamali A. Hospitalization Trends for Acute Kidney Injury in Kidney Transplant Recipients in the United States, 2004-2014. Transplantation. 2019

242. Astor BC, Djamali A, Mandelbrot DA, Parajuli S, Melamed ML. The Association of 25-Hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database. Transplantation. 2019

243. Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N,



Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney Int Rep. 2019

244. Aziz F, Jorgenson MR, Parajuli S, Zhong W, Hidalgo LG, Djamali A, Mandelbrot D, Odorico J, Sollinger H, Astor BC, Mohamed MA. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant. Transpl Infect Dis. 2020

245. Brogan M, Astor BC, Melamed ML. Vitamin D in chronic kidney disease: is there a role outside of PTH control? Curr Opin Nephrol Hypertens. 2020

246. Hennes AJ, Holdener KE, Burlingham WJ, Mandelbrot DA, Parajuli S, Mohamed MA, Garg N, Aziz F, Astor BC, Djamali A. Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients. Transplant Direct. 2020

247. Vogel SL, Singh T, Astor BC, Waheed S. Gender differences in peritoneal dialysis initiation in the US end-stage renal disease population. Perit Dial Int. 2020

248. Lyu B, Jorgenson M, Hansen KE, Djamali A, Astor BC. Proton Pump Inhibitors, But Not H2 Receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients. Transplantation. 2020

249. Jorgenson MR, Descourouez JL, Lyu B, Astor BC, Saddler CM, Mandelbrot DA, Parajuli S. Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipients. Clin Transplant. 2020

250. Lyu B, Hansen KE, Jorgenson MR, Astor BC. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients. Am J Nephrol. 2020

251. Machhi R, Mandelbrot DA, Al-Qaoud T, Astor BC, Parajuli S. Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma. Am J Nephrol. 2020

252. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, Graham J, Moist LM, Rajan DK, Roberts C, Vachharajani TJ,Valentini RP; National Kidney Foundation. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020

253. Parajuli S, Muth BL, Astor BC, Redfield RR, Mandelbrot DA, Odorico JS, Djamali A, Kaufman DB. Delayed kidney graft function in simultaneous pancreas-kidney transplant recipients is associated with early pancreas allograft failure. Am J Transplant. 2020

254. Garg N, Hidalgo LG, Ellis TM, Redfield RR, Parajuli S, Mezrich JD, Kaufman DB, Astor BC, Djamali A, Mandelbrot DA. Third-party vessel allografts in kidney and pancreas transplantation: Utilization, de novo DSAs, and outcomes. Am J Transplant. 2020

255. Matchett CL, Astor BC, Maursetter LJ. Factors Associated with Nephrology Fellowship Program Fill Rates. Clin J Am Soc Nephrol. 2020

256. Tangri N, Ferguson TW, Wiebe C, Eng F, Nash M, Astor BC, Lam NN, Ye F, Shin JI, Whitlock R, Yuen DA. Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients. Can J Kidney Health Dis. 2020



257. Parajuli S, Swanson KJ, Patel R, Astor BC, Aziz F, Garg N, Mohamed M, Al-Qaoud T, Redfield R, Djamali A, Kaufman D, Odorico J, Mandelbrot DA. Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study. Transpl Int. 2020

258. Aziz F, Mandelbrot D, Singh T, Parajuli S, Garg N, Mohamed M, Astor BC, Djamali A. Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019.Transplant Proc. 2020

259. Churpek MM, Carey KA, Edelson DP, Singh T, Astor BC, Gilbert ER, Winslow C, Shah N, Afshar M, Koyner JL. Internal and External Validation of a Machine Learning Risk Score for Acute Kidney Injury. JAMA Netw Open. 2020

260. Aziz F, Jung-Hynes B, Parajuli S, Redfield RR, Astor BC, Mandelbrot D, Hidalgo L, Djamali A. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years. Clin Nephrol. 2020

261. Machhi R, Mandelbrot DA, Al-Qaoud T, Astor BC, Parajuli S. Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma. Am J Nephrol. 2020

262. Singh T, Kharadjian TB, Astor BC, Panzer SE. Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease.Clin Transplant. 2020

263. Srivastava A, Bodnar J, Osman F, Jorgenson MR, Astor BC, Mandelbrot DA, Parajuli S. Serum Albumin Level Before Kidney Transplant Predicts Post-transplant BK and Possibly Cytomegalovirus Infection. Kidney Int Rep. 2020

Chapters in Books

Shatin D, Bright RA, Astor BC. Databases for studying the epidemiology of implanted medical devices. In: Johnson FE, Virgo KS, editors. The Bionic Patient. St. Louis: Mosby, 2005.

Yevzlin AS, Astor BC. Future Directions in Vascular Access Clinical Science. In: Chan

MR, Yevzlin AS, Arif A, editors. Vascular Access for the General Nephrologist. Nova Science Publishers, 2012

Invited Research Presentations

Local

UW Department of Medicine Grand Rounds, 2010 Predictors and Consequences of Chronic Kidney Disease: Emerging Markers of Risk

UW Department of Population Health Sciences Grand Rounds, 2014 Novel Markers of Function and Risk in Native and Transplanted Kidneys

UW Department of Medicine Grand Rounds, 2017 Recent Advances in Novel Biomarkers for Cardiorenal Outcomes UW Division of Nephrology Grand Rounds, 2018



Vitamin D in Kidney Transplant Recipients: Translating Results from the General Population UW Division of Nephrology Grand Rounds, 2019 Updated Vascular Access Clinical Practice Guidelines: A New Patient-Specific Paradigm

National/International

Annual Meeting of the American Society of Nephrology; Philadelphia, PA, 2002 No association between homocysteine and the risk of vascular access interventions among incident hemodialysis patients: the CHOICE Study American Association for Clinical Chemistry, Upstate New York Section; Rochester, NY, 2002 Applications of kidney function measurements to research and clinical populations National Kidney Foundation Spring Clinical Meeting; Dallas, TX, 2003 The burden of chronic kidney disease: Lessons from NHANES Annual Meeting of the American Society of Nephrology; San Diego, CA, 2006 Glomerular filtration rate, albuminuria and risk of cardiovascular mortality in the US population Roche Anaemia Academy; Budapest, Hungary, 2006 Chronic kidney disease: a continuum of risk NIH Scientific Forum on Chronic Kidney Disease; Baltimore, MD, 2007 Advancing CKD Research in Established Cohort Studies

Annual Meeting of the American Society of Nephrology; San Francisco, CA , 2007 Glomerular Filtration Rate Estimated by Cystatin C or Creatinine is an Independent Risk Factor for Cardiovascular Mortality in the US Population Annual Meeting of the American Society of Nephrology; San Francisco, CA, 2007 Decreased GFR and Albuminuria: The Individual and Combined Risk with Incident CVD Annual Meeting of the American Society of Nephrology; Philadelphia, PA, 2008 Chronic kidney disease in the elderly: Lessons from NHANES Johns Hopkins School of Medicine, Division of Nephrology Grand Rounds; Baltimore, MD, 2010 Novel Markers of Kidney Function as Predictors of Mortality in the Atherosclerosis Risk in Communities (ARIC) Study University of Maryland School of Medicine, Division of Nephrology Grand Rounds; Baltimore, MD, 2010 Predictors and Consequences of Chronic Kidney Disease: Emerging Markers of Risk Annual Meeting of the American Society of Hypertension; New York, NY, 2010



Update: Bio Markers as a Tool to Assess Renal Risk and Renal Injury Annual Meeting of the American Society of Nephrology; Denver, CO, 2010 Trefoil Factor 3 Predicts Incident Chronic Kidney Disease in the General Population: The Atherosclerosis Risk in Communities (ARIC) Study and Framingham Heart Study Annual Meeting of the American Society of Nephrology; Denver, CO, 2010 Novel Markers of Kidney Function as Predictors of Mortality in the Atherosclerosis Risk in Communities (ARIC) Study Cardiometabolic Health Congress, Boston, MA, 2011 CKD – Is It a MI Equivalent? American Transplant Congress; Boston, MA, 2012 Serum β2-microglobulin at discharge predicts outcomes following kidney transplantation Albert Einstein College of Medicine, Division of Nephrology Grand Rounds; New York, NY, 2012 Predictors and Consequences of Chronic Kidney Disease: Emerging Markers of Risk University of Alabama School of Public Health, Department of Epidemiology Grand Rounds; Birmingham, AL, 2014 Novel Markers of Function and Risk in Native and Transplanted Kidneys University of Toronto, Division of Nephrology Grand Rounds: Toronto, Ontario, Canada, 2016 Utility of Biomarkers in Native and Transplanted Kidneys University of Chicago, Division of Nephrology Grand Rounds; Chicago IL, 2018 Novel Biomarkers for Outcomes in Native and Transplant Kidney Disease

Educational Activities & Presentations Classroom Teaching Johns Hopkins Bloomberg School of Public Health (graduate students) Observational Epidemiology (Course Co-Director) – 2006-2009 Biological Basis of Cardiovascular Disease (Course Director) – 2004, 2006, 2008 Epidemiologic and Preventive Aspects of Cardiovascular Disease (Lecturer) – 2005-8 (Course Director) – 2010, 2011 Intermediate Epidemiology (Course Co-director) - 2002-2005 Introduction to the Biomedical Sciences (Lecturer) - 2002-2010 Introduction to Diabetes and Obesity Epidemiology (Lecturer) - 2010 Johns Hopkins University School of Medicine (medical students)

Clinical Epidemiology (Lecturer) - 2003-10; (Small Group Instructor) – 2003-6, 2008-10 Methods in Clinical Research (Small Group Instructor) - 2003-6

Johns Hopkins University, Zanvyl Krieger School of Arts and Sciences (undergraduates)



Introduction to Epidemiology (Lecturer) – 2006, 2010 University of Wisconsin School of Medicine and Public Health

Cardiovascular Disease Epidemiology (Course Director) – 2011, 2013, 2015, 2017, 2019 (graduate students)

Population Medicine and Epidemiology (Small Group Instructor) – 2013-14 (medical students)

Body in Balance (Small Group Instructor) – 2016-7 (medical students) Socioeconomic Disparities in Chronic Kidney Disease (Panel Discussant) – 2016-7

(medical students) Population Health Sciences Graduate Research Seminar (Course Director) – 2016

(graduate students) Population Health Sciences Graduate Research Seminar (Course Co-Director) – 2020

(graduate students)

Mentoring PhD Advisees

Stella Yi, MPH, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2008 Dissertation: Endogenous hormones in the development of cardiovascular disease in

African-Americans with kidney disease Current position: Assistant Professor, Department of Population Health, NYU School of

Medicine, New York, NY Lori Bash, MPH, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2009 Dissertation: Understudied risk factors and consequences of decreased estimated

kidney function in the Atherosclerosis Risk in Communities (ARIC) Study: a closer look at hospital and administrative data

Current position: Outcomes Research Scientist, Merck & Co, Inc., Kenilworth, NJ Nrupen Bhavsar, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2010 Dissertation: Subclinical albuminuria, beta trace protein, neutrophil gelatinase-

associated lipocalin, and kidney injury molecule 1 and risk of coronary heart disease, chronic kidney disease and death.

Current position: Assistant Professor, Department of Medicine, Duke University School of Medicine, Durham, NC

Jung-Im Shin, MD, PhD

Granted PhD in Epidemiology, University of Wisconsin School of Medicine and Public Health, 2016

Dissertation: End-Stage Renal Disease: Improving Outcomes by Identifying High-risk Patients and Providing Effective Treatment

Current position: Assistant Scientist, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD



Beini Lyu, MD PhD Candidate in Epidemiology, University of Wisconsin School of Medicine and Public

Health, 2017-current Maria Schletzbaum, MD/PhD (Epidemiology) candidate, University of Wisconsin School

of Medicine and Public Health, 2018-current Retention in healthcare among young patients with lupus

Thesis Committee Member

Edwina H. Yeung, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2008 The effects of weight loss and of macronutrient intake without weight loss on adiponectin

levels: a study nested in the Fatty Liver Look-AHEAD Ancillary and OMNI-Heart Studies.

Current position: Investigator, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD

S. Joseph Kim, MD, MHS, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2009 The “center effect” in kidney transplantation: A new look at an old problem. Current position: Associate Professor, Department of Medicine, University of Toronto,

Toronto, Ontario Bethany Barone, ScM, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2010 Effects of exercise on endothelial function in men and women with and without Type 2

Diabetes. Current position: Associate Professor, Department of Health and Human Development

and Clinical and Translational Science, University of Pittsburgh School of Education, Pittsburgh, PA

Julio Lamprea, MD, MPH, PhD Granted PhD in Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2012 The dyslipidemia of chronic kidney disease and its association with coronary heart

disease risk Current position: Cardiology Fellow, University of Washington School of Medicine,

Seattle, WA Lina Vera Cala, MD, MSc, PhD Granted PhD in Epidemiology, University of Wisconsin School of Medicine and Public

Health, 2012 Factors Associated with Hypertension Awareness, Treatment, and Control in Latin

America Current position: Chair, Department of Public Health, Universidad Industrial de

Santander, Bucaramanga, Colombia

Pravleen Bajwa, PhD Candidate, Epidemiology, University of Wisconsin School of Medicine and Public Health, 2018-current

A risk prediction model for hypertension among Latin Americans



MPH and MS Advisees

Ali Yawar Alam, MPH, Johns Hopkins Bloomberg School of Public Health, 2006 Changes in carotid artery intima media thickness with long-term statin use among

diabetic and non-diabetic patients: The Atherosclerosis Risk in Communities (ARIC) Study.

Current position: Ministry of Health, Riyadh, Saudi Arabia Navin Jaipaul, MHS, Epidemiology, Johns Hopkins Bloomberg School of Public Health,

2006. Arteriovenous access-specific association of phosphorus and calcium phosphorus

product with vascular access interventions in hemodialysis patients. Current position: Nephrologist, Loma Linda University Health Anitha Byreddy, MPH, Johns Hopkins Bloomberg School of Public Health, 2006. Metabolic acidosis and mortality in hemodialysis patients: The CHOICE Study. Current position: Nephrologist, Grand Prairie, TX Seema Hasan, MPH, Johns Hopkins Bloomberg School of Public Health, 2008. Grant Proposal For Health Achievement By Implementing Tobacco-control measures in

School children (HABITS)- a Program To Protect Pakistani Minors from the Hazards of Tobacco Use.

Sithu Win, MPH, Johns Hopkins Bloomberg School of Public Health, 2009. Kidney dysfunction is associated with faster progression of left ventricular hypertrophy Current position: Assistant of Medicine, Johns Hopkins Medicine, Baltimore, MD Dong Yeob Ha, MPH, Johns Hopkins Bloomberg School of Public Health, 2010. Strict control of blood glucose increases cognitive impairment and morbidity of the

patients with Type 2 diabetes mellitus.

Nephrology Fellows, University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Nephrology

Dawn Wolfgram, MD, 2011-2 The association between dialysis modality and cognitive decline among incident dialysis

patients Current position: Assistant Professor, Department of Medicine, Medical College of

Wisconsin, Milwaukee, WI Mohsen Elramah, MD, 2012-4 Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-

minute inflation times Current position: Nephrologist, Imperial, CA Liliana Osadchuk, MD, 2013-4 Outcomes in Kidney Transplant Recipients with Post-Transplant DSA in the Absence of

Antibody-Mediated Rejection Current position: Assistant Professor, Department of Medicine, Medical College of

Wisconsin, Milwaukee, WI



Amanda Valliant, MD, 2013-5 Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with

increased rate of bacteremia Current position: Nephrologist, Wichita, KS Lamya Boujelbane, MD, 2013-5 Percutaneous versus surgical insertion of PD catheters in dialysis patients: a meta-

analysis Current position: Nephrologist, Cottonwood, AZ Nish Saxena, MD, 2015-7 A single center kidney transplant experience among ten Caucasian females with end-

stage renal disease due to scleroderma Current position: Nephrologist, Cottonwood, AZ Ning Fu, MD, 2015-6 A meta-analysis of stent placement vs. angioplasty for dialysis vascular access stenosis Current position: Nephrologist, San Jose, CA Ali Gardezi, MD, 2015-6 Erosion of the silicone peritoneal dialysis catheter with the use of gentamicin cream at

the exit site Current position: Assistant Professor, Division of Nephrology, Department of Medicine,

University of Wisconsin School of Medicine and Public Health Other Fellows

Katelyn Richard, PharmD, School of Pharmacy, 2012-3 Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized

renal transplant recipients Current position: Clinical pharmacist, Beth Israel Deaconess Medical Center, Boston,

MA Jyoti Brar, MD, Department of Surgery, 2013-4 Incidence and Predictors of Renal Allograft Loss following Non-HLA Antibody Mediated

Rejection Current position: Nephrologist, De Pere, WI Matthew Tattersall, DO, MS, Division of Cardiovascular Medicine, 2013-4 Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic

Study of Atherosclerosis Current position: Assistant Professor, Division of Cardiovascular Medicine, Department

of Medicine, University of Wisconsin School of Medicine and Public Health Adam Gepner, MD, Division of Cardiovascular Medicine, 2013-4 Longitudinal effects of a decade of aging on carotid artery stiffness: the multiethnic study

of atherosclerosis. Current position: Clinical Adjunct Assistant Professor, Division of Cardiovascular

Medicine, Department of Medicine, University of Wisconsin School of Medicine and



Public Health Robert Redfield, MD, Department of Surgery, 2013-2015 Current outcomes of chronic active antibody mediated rejection - A large single center

retrospective review using the updated BANFF 2013 criteria Current position: Assistant Professor, Department of Surgery, University of Wisconsin

School of Medicine and Public Health Amanda Condon, PharmD, School of Pharmacy, 2016-7 Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors

and Outcomes from the Wisconsin Allograft Recipient Database (WisARD) Current position: Transplant pharmacy fellow, University of Wisconsin School of

Pharmacy University of Wisconsin School of Medicine and Public Health – Residents and Undergraduate Students

Kevin Chapla, MD, 2015-6 (resident) Hemodialysis catheter locking solutions and the prevention of catheter dysfunction Current position: Fellow, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health Joel Rosenberg, 2015-7 (undergraduate student) The association of mineral metabolism with vascular access patency Current position: medical student at University of Minnesota Medical School Emily Joachim, MD, 2016-7 Association of pre-transplant dialysis modality and post-transplant outcomes Current position: Fellow, Division of Nephrology, Department of Medicine, University of

Wisconsin School of Medicine and Public Health Amber Hertz-Tang, MD, 2016-7 BK viremia is not associated with adverse outcomes in the absence of BK nephropathy Current position: Fellow, Division of Nephrology, Department of Medicine, University of

Wisconsin School of Medicine and Public Health

University of Wisconsin School of Medicine and Public Health – Shapiro Students (medical students; co-mentor)

Steve Peery, 2017 Cause of ESRD is not associated with risk of post-transplant CMV infection Savannah Vogel, 2017 Association of Gender with the Utilization of Peritoneal Dialysis Callie Plafkin, 2017 Kidney transplant patients recipients with polycystic kidney disease have a lower risk of post-transplant BK infection compared to than those with other causes of end-stage renal disease due to other causes



Sarah Di Bartolomeo, 2018 Outcomes of Pre-Transplant Melanoma in Kidney Transplant Recipients with Pre-Transplant Melanoma Jakob Ohman, 2018 Should Peritoneal Dialysis-First be Considered in the Older Population? Stacey Rolak, 2018 Outcomes of two diarrhea-causing infections in kidney transplant recipients Vivian Gama, 2018 Survival Outcomes for Post Graft Failure Patients on Peritoneal Dialysis

Faculty Mentoring Committee

Martin Dibs, MD, Department of Surgery, University of Wisconsin School of Medicine and Public Health, 2017-present

Service Activities

Departmental Johns Hopkins Bloomberg School of Public Health

Comprehensive examination committee, 2005-2010 (Chair: 2008-10) Curriculum committee, 2005-2009

Genetic epidemiology search committee, 2008 Faculty executive committee, 2008-2011 University of Wisconsin School of Medicine and Public Health Director of Research, Division of Nephrology, 2011-present

Department of Medicine Research Day planning committee, 2012, 2015-present (Chair, 2018)

Department of Population Health Sciences admissions committee, 2012-2014 Department of Population Health Sciences Epidemiology steering committee, 2013-

present Department of Medicine Information Systems Committee, 2014-present (chair) Department of Medicine Research Committee, 2014-present Department of Population Health Sciences qualifying exam committee, 2014-present UWSMPH/Hospital Wisconsin Network for Health Research (WiNHR) Advisory Committee, 2015-present Data Safety and Monitoring Board (DSMB) - Chair; A Phase I/II, Single Center,

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Human Recombinant C1 Inhibitor (RUCONEST®) as a therapeutic strategy to reduce the incidence of Delayed Graft Function in recipients of kidneys from Donation after Cardio-circulatory Death; SMPH Department of Surgery

National/International



Evidence Review Team; National Kidney Foundation's Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification, 2000-2002 Steering Committee member; National Kidney Foundation study of physician recognition of chronic kidney disease in patients with type 2 diabetes; 2010-2014 Writing Group member; KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD, 2012-2013 Work group member, National Kidney Foundation Kidney Disease Outcomes Quality Initiative, 2013-2014 Member, Scientific Registry of Transplant Recipients (SRTR) Technical Advisory Committee; 2013-2015 Committee Member, National Kidney Foundation 2017 Update of KDOQI Clinical Practice Guidelines for Vascular Access; 2016-2019

Grant Reviews

NIH/NIDDK Special Emphasis Committee, 2006, 2007, 2011, 2013, 2015-8 NIH/NIDDK SBIR, 2016-2018 NIH/NIDDK Kidney Disease, Nutrition, Obesity and Diabetes Study Section (Ad Hoc

Reviewer), 2013-19; Standing member 2019-present NIH/NIDDK X01 Study Section (Ad Hoc Reviewer), 2014, 2017 NIH/NIDDK Ancillary Studies Study Section (Ad Hoc Reviewer), 2014, 2016-7 Board of Scientific Counselors (Ad Hoc Reviewer,); NIH/NIDDK, 2010 University of Wisconsin School of Medicine and Public Health ICTR Pilot Studies; 2013-4 AXA Research Fund (France), 2010 National Institute for Health Research, West Midlands (UK), Patient Benefit (RfPB)

Programme, 2010 Health Research Board (Ireland), 2012 Wellcome Trust Fellowship, 2015

Abstract Reviews American Society of Nephrology Annual Scientific Meeting, 2007, 2011, 2015 American Heart Association Epidemiology and Prevention Section, 2014, 2016-7 Editorial Activities

Editorial Board: Kidney International Reports BMC Nephrology Peer Reviewer: American Journal of Kidney Diseases American Journal of Nephrology American Journal of Transplantation Annals of Internal Medicine Atherosclerosis



Circulation Clinical Trials Epidemiology Environmental Research Journal of the American College of Cardiology Journal of Clinical Epidemiology Journal of General Internal Medicine JAMA Journal of the American Society of Nephrology Kidney International The Lancet Nephrology, Dialysis and Transplantation PLos One Transplantation Transplant International

michael l - pophealth.wisc.edu

Documents